Credit: Getty Images. Evidence suggests that patent ductus arteriosus comprises anywhere from 5% to 10% of all congenital heart disease. Although the majority of congenital heart diseases (CHD) are ...
Similar rates of survival without severe morbidity versus placebo in PDA trial ...
Pediatric experts from Le Bonheur’s Heart Institute and the University of Tennessee Health Science Center will present lectures, posters, abstracts and hands-on workshops. Pediatric experts from Le ...
Transcatheter PDA closure has been a mainstay in congenital interventional cardiology for decades, but very low birth weight infants were once excluded due to access challenges and the lack of ...
Merit Medical Systems initiates a study to evaluate the Bloom Micro Occluder System for treating patent ductus arteriosus in premature infants. Merit Medical Systems, Inc. has announced the enrollment ...
Transcatheter PDA closure has been a mainstay in congenital interventional cardiology for decades, but very low birth weight infants were once excluded due to access challenges and the lack of ...